FY2023 EPS Estimates for Inspira Technologies Oxy B.H.N. Ltd. Raised by Diamond Equity (NASDAQ:IINN)

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN – Free Report) – Equities researchers at Diamond Equity boosted their FY2023 earnings per share estimates for Inspira Technologies Oxy B.H.N. in a research note issued to investors on Thursday, September 7th. Diamond Equity analyst H. Diamond now anticipates that the company will post earnings per share of ($1.18) for the year, up from their previous estimate of ($1.35). The consensus estimate for Inspira Technologies Oxy B.H.N.’s current full-year earnings is ($1.35) per share.

Get Inspira Technologies Oxy B.H.N. alerts:

Inspira Technologies Oxy B.H.N. Trading Up 6.8 %

Shares of IINN stock opened at $1.41 on Monday. Inspira Technologies Oxy B.H.N. has a 1-year low of $0.98 and a 1-year high of $1.99. The stock’s 50-day moving average is $1.40 and its 200 day moving average is $1.40. The company has a quick ratio of 4.11, a current ratio of 4.11 and a debt-to-equity ratio of 0.14.

Institutional Investors Weigh In On Inspira Technologies Oxy B.H.N.

Several institutional investors have recently added to or reduced their stakes in IINN. Renaissance Technologies LLC acquired a new stake in Inspira Technologies Oxy B.H.N. in the second quarter worth about $41,000. Citadel Advisors LLC acquired a new stake in shares of Inspira Technologies Oxy B.H.N. during the third quarter worth about $63,000. Two Sigma Investments LP acquired a new stake in shares of Inspira Technologies Oxy B.H.N. during the third quarter worth about $30,000. Finally, Ieq Capital LLC acquired a new stake in shares of Inspira Technologies Oxy B.H.N. during the first quarter worth about $70,000.

About Inspira Technologies Oxy B.H.N.

(Get Free Report)

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.

Recommended Stories

• Five stocks we like better than Inspira Technologies Oxy B.H.N.
• Why Special Dividends Can be a Delightful Surprise for Income Investors
• MarketBeat Week in Review – 9/4 – 9/8
• How to Invest in Artificial Intelligence
• The Best 5 Small Cap AI Companies to Buy Now
• 3 Small Caps With Big Return Potential
• Miso Robotics Stock: Is an IPO Coming Soon?

Receive News & Ratings for Inspira Technologies Oxy B.H.N. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspira Technologies Oxy B.H.N. and related companies with MarketBeat.com's FREE daily email newsletter.